Environmental Risk Consulting

A viral image of an ATM in Ludhiana recently caught my attention - a dangerously steep ramp ending abruptly at a glass door, with a staircase running alongside that leads nowhere. A perfect reminder of a hard-earned lesson in fintech: "Compliance isn’t just a checkbox." Product Managers: You don't want to miss saving 💾 this post for your future reference. This ramp was technically "compliant" - yes, there was a wheelchair access ramp. But it completely missed the purpose of accessibility. People had angry comments on social media about the apathy with which wheelchair-bound customers were treated and how the bank had made a mockery of accessibility. No amount of regulation can account for 'compliance as a checkbox' implementations that are designed to meet the regulation but not serve their intended purpose. It's the same trap I've seen countless fintech products fall into - implementing regulations as mere checkboxes rather than embracing them as design principles. I've experienced regulatory hurdles umpteen times in product launches; in fact, I've never experienced a straightforward implementation that hasn't hit a regulatory roadblock. BUT I can say this confidently: Compliance-first design is the secret sauce that makes the battle easier and less arduous, and inarguably 'faster' IF You just stick to the first principles of building this into your product strategy from day one . Regulations can either slow you down or become your competitive edge. To make compliance your strategic advantage, here's my 3-step playbook: 1/ Design Integration: Make regulatory adherence a natural part of the user experience rather than an afterthought ↳Embed compliance requirements into your initial product design ↳Get feedback from legal and compliance teams, and even the regulator if needed ↳Validate, Test, Iterate, Repeat 2/ Cross-Functional Collaboration: Build bridges between product, legal/compliance teams from day one ↳Involve them early ↳Make compliance & legal stakeholders brainstorm and provide feedback ↳Balance innovation with regulatory requirements using case studies and data to back up assertions instead of getting into crosshairs with them 3/ Validate Early, Validate Often: ↳Test with real scenarios ↳Get early feedback from regulators ↳Regular compliance assessments, no matter what stage of development you are in One golden tip - document everything, err on the side of caution when it comes to building and fostering trust with legal and compliance counterparts. The lesson in one line? Build WITH compliance, not around it. Instead of working around regulations, let's build with them. Because when you design within the right guardrails, innovation doesn't just survive—it scales. What's your strategy for managing fintech compliance? Share below. 👍 LIKE this post, 🔄 REPOST this to your network and follow me, Monica Jasuja

𝗛𝗲𝗿𝗲'𝘀 𝗺𝘆 𝟳-𝘀𝘁𝗲𝗽 𝗽𝗹𝗮𝘆𝗯𝗼𝗼𝗸 𝗳𝗼𝗿 𝗲𝗻𝘀𝘂𝗿𝗶𝗻𝗴 𝘀𝗺𝗼𝗼𝘁𝗵 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝘀𝘂𝗯𝗺𝗶𝘀𝘀𝗶𝗼𝗻𝘀 𝘁𝗵𝗮𝘁 𝗜'𝘃𝗲 𝗿𝗲𝗳𝗶𝗻𝗲𝗱 𝗼𝘃𝗲𝗿 𝘆𝗲𝗮𝗿𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗮𝗻𝗱 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝘀𝗽𝗮𝗰𝗲: 𝟭. 𝗦𝘁𝗮𝗿𝘁 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝗲𝗻𝗱 𝗶𝗻 𝗺𝗶𝗻𝗱 - 𝟭𝟴-𝟮𝟰 𝗺𝗼𝗻𝘁𝗵𝘀 𝗯𝗲𝗳𝗼𝗿𝗲 𝘀𝘂𝗯𝗺𝗶𝘀𝘀𝗶𝗼𝗻 • Map your regulatory strategy to your commercial goals • Identify your regulatory pathway early (510(k), De Novo, PMA) • Build testing protocols based on predicate devices when applicable 𝟮. 𝗗𝗲𝘀𝗶𝗴𝗻 𝘆𝗼𝘂𝗿 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗦𝘆𝘀𝘁𝗲𝗺 𝗳𝗼𝗿 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆 • Implement ISO 13485 principles from day one • Focus on the 7 critical SOPs that impact submissions most • Avoid the common trap of documentation overload (I've seen startups with 200+ SOPs when 35-40 would suffice) 𝟯. 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗲 𝘆𝗼𝘂𝗿 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 𝗺𝗲𝘁𝗵𝗼𝗱𝗼𝗹𝗼𝗴𝘆 𝗯𝗲𝗳𝗼𝗿𝗲 𝗲𝘅𝗲𝗰𝘂𝘁𝗶𝗻𝗴 • Pre-validate test methods with 3-5 pilot runs • Engage with testing labs that have FDA submission experience • Document protocol deviations properly (we found 63% of submissions get delayed due to inadequate deviation management) 𝟰. 𝗟𝗲𝘃𝗲𝗿𝗮𝗴𝗲 𝗽𝗿𝗲-𝘀𝘂𝗯𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝗺𝗲𝗲𝘁𝗶𝗻𝗴𝘀 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰𝗮𝗹𝗹𝘆 • Schedule Q-Sub meetings 9-12 months before planned submission • Prepare focused questions (limit to a few critical issues) • Follow up with written summaries within the allocated time 𝟱. 𝗕𝘂𝗶𝗹𝗱 𝗮 𝘀𝘂𝗯𝗺𝗶𝘀𝘀𝗶𝗼𝗻 "𝘄𝗮𝗿 𝗿𝗼𝗼𝗺" • Assemble cross-functional team (R&D, Clinical, Quality, Regulatory) • Create submission trackers with accountability metrics • Hold twice-weekly stand-ups in the 90 days before submission 𝟲. 𝗖𝗼𝗻𝗱𝘂𝗰𝘁 𝘁𝗵𝗶𝗿𝗱-𝗽𝗮𝗿𝘁𝘆 𝘀𝘂𝗯𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝗿𝗲𝘃𝗶𝗲𝘄 • Have external experts review 100% of your technical documentation • Use submission management platforms like RADAR or MasterControl • Schedule review 45-60 days before planned submission date 𝟳. 𝗣𝗿𝗲𝗽𝗮𝗿𝗲 𝗳𝗼𝗿 𝗶𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝘃𝗲 𝗿𝗲𝘃𝗶𝗲𝘄 • Anticipate FDA questions with "pre-mortem" analysis • Have subject matter experts on standby during review period • Create response templates for common deficiency categories I learned these lessons the hard way. Early in my career I worked at a company where we had three submissions rejected due to inconsistent test data formatting. Now we use standardized data presentation templates that have cut our Additional Information requests by 72%. 𝗧𝗔𝗞𝗘𝗔𝗪𝗔𝗬: Regulatory success is about methodical preparation and strategic execution. The companies that view regulatory as a strategic function rather than a compliance burden consistently outperform their peers in time-to-market by an average of 7 months If you're preparing for an FDA submission in the next 12-18 months, I'd be happy to share our pre-submission checklist. Just message me directly

Harnessing living organisms to restore polluted environments is a reminder that nature itself provides solutions to human-made challenges. Biotechnology’s ability to clean soil, water, and air highlights the intersection of science, sustainability, and economic feasibility. Bioremediation leverages microorganisms and plants to break down pollutants in soil, water, and air, offering a natural and effective approach to environmental cleanup. Microbial solutions, such as oil-degrading bacteria, help mitigate spills, while phytoremediation uses plants like sunflowers and poplars to absorb heavy metals. These methods are widely applied in industries where contamination is a concern, including agriculture, energy, and chemical production. However, success depends on understanding site-specific conditions, regulatory compliance, and long-term effectiveness. Strategic planning ensures these solutions remain cost-efficient, adaptable, and capable of meeting sustainability goals while reducing environmental risks. #Biotechnology #Bioremediation #Sustainability #EnvironmentalTech

How to Navigate HealthTech Regulations Without Slowing Down Innovation. Here's how to turn compliance into your competitive edge: Many founders stumble because they view regulations as hurdles to jump over, rather than as pathways to build trust and scale sustainably. 1. Start with Compliance at the Core Regulatory requirements like FDA, GDPR, HIPAA, and MHRA aren’t afterthoughts - they're the foundation of your product strategy. By designing for compliance from day one, you save time and money down the road. 2. Leverage Regulatory Milestones as Credibility Markers Each certification or clearance you achieve is not just a box checked - it’s a marketing tool. Clinicians and administrators want proof your solution is safe, effective, and trustworthy. Use these achievements to open doors. 3. Balance Speed with Safety Yes, HealthTech needs to move faster, but it also deals with life-critical outcomes. Aim to accelerate innovation within regulatory boundaries. Agile development practices and early engagement with regulators can help you iterate quickly without breaking the rules. 4. Build a Regulatory-Ready Team Your team should include compliance experts who know the intricacies of the healthcare landscape. They’re not just there to “fix” issues - they’re strategic partners in shaping your roadmap. 5. Stay Ahead of Changing Policies Healthcare is constantly evolving. New privacy laws, funding models, and standards can make or break your market position. Make monitoring and adapting to these shifts a continuous process - not a reactive one. 6. Turn Compliance Into a Value Proposition Your ability to meet stringent regulatory standards isn’t just a necessity - it’s a differentiator. Customers will trust your product more if you can show you’re a step ahead in safeguarding their data and patients' lives. Innovation and regulation don’t have to be at odds. When done right, compliance isn’t a barrier - it’s your bridge to trust, scalability, and long-term success. If you found this useful, repost ♻️ to help your network. And follow me (Kevin McDonnell) for more like this. P.S. If this resonates and you want help with this, book a free 30-minute strategy call here 👉 https://lnkd.in/e3ibNsss

How Banks Ensure Regulatory Compliance: Conducting Treasury Activities Regulatory compliance is a cornerstone of modern banking, ensuring financial institutions operate within legal frameworks. For banks, particularly in treasury activities, maintaining compliance is crucial to uphold trust, manage risk, and avoid significant penalties. Here is how banks ensure regulatory compliance in their treasury operations: Understanding Regulatory Requirements: Banks must have a comprehensive understanding of relevant regulations, including international directives and national rules. These cover capital adequacy, liquidity management, and risk assessment. Robust Internal Controls: Implementing robust internal controls is essential. Compliance departments monitor and enforce adherence to regulatory standards through regular audits and reviews of treasury activities. Effective Risk Management: Banks use risk management frameworks to identify, assess, and mitigate risks in their treasury operations. This includes market risk, credit risk, and operational risk, maintaining a conservative approach. Training and Education: Continuous training ensures staff are aware of regulatory changes and understand their roles in compliance. Specialised training for treasury staff focuses on specific compliance requirements. Technology and Automation: Advanced software solutions monitor transactions, manage data, and generate compliance reports. These tools detect potential compliance issues in real-time for prompt corrective actions. Regular Reporting and Documentation: Accurate and timely reporting to regulatory bodies is essential. Comprehensive documentation of all treasury activities ensures transparency and provides a clear audit trail. Engagement with Regulators: Proactive engagement with regulators keeps banks informed about upcoming regulatory changes and provides guidance on compliance matters, addressing issues before they escalate. Scenario Analysis and Stress Testing: Conducting scenario analysis and stress testing helps ensure compliance under various market conditions. Banks assess the impact on their treasury activities to ensure they can withstand adverse conditions. Ensuring regulatory compliance in treasury activities is a multi-faceted process requiring understanding regulations, implementing robust controls, managing risks, continuous education, leveraging technology, accurate reporting, engaging with regulators, and conducting scenario analysis. By prioritising compliance, banks navigate the complexities of the regulatory landscape, contributing to the stability and integrity of the financial system.

Build fast, but read the fine print faster Every founder wants to build fast. Speed is the oxygen of a #Startup. But there’s a reason oxygen tanks come with pressure valves— Because unregulated speed? It explodes. & nowhere is that truer than when it comes to #Compliance. Most founders treat compliance like a dentist appointment— Important. Uncomfortable. & something you push off… until it hurts. You’re moving fast, breaking things, pitching, building, shipping. Then one day... a #Regulator calls. Or worse—a lawsuit lands. Suddenly, you’re no longer the disruptor. You’re the defendant. ⚠️ If you touch money, data, or identity—you're already regulated You just don’t know it yet. & compliance isn’t a “later” problem. It’s a right-now-or-risk-everything problem. According to ComplyAdvantage: • 67% of high growth startups faced regulatory scrutiny by Series A • Another 23% faced enforcement actions that delayed funding, froze accounts, or triggered audits That’s 1 in 4 #Startups derailed because they didn’t read the fine print. 😬 The classic founder mistake? • MVP? ✅ • Pitch deck? ✅ • Fancy hoodies? ✅ • #ComplianceStrategy? ❌ • Regulatory exposure map? ❌❌ You don’t know what’s in the terms of your own API partner. You didn’t realize your onboarding flow violates 3 KYC requirements. You launched in a new region...but forgot to check if you’re even allowed to. & suddenly, that momentum you were scaling? It’s now evidence. Startups that treat compliance like an afterthought eventually find themselves running a company they no longer control. According to a 2023 McKinsey report, 43% of #fintech & #Web3 startups that scaled rapidly without regulatory alignment faced critical legal or operational slowdowns within 24 months. Some never recovered. Meanwhile, those that built compliance into their core strategy raised more capital, landed better partnerships, & stayed alive long enough to matter. Because compliance doesn’t slow you down—it keeps you from getting shut down. 👨💼 My advice to founders I’ve built & led startups across #RegulatedMarkets & here’s what I’ve learned: Compliance is either your moat or your mess. You choose. What I tell every founder I mentor: • If you're moving fast, move legally. You can’t scale trust after you’ve lost it. • Bring in a guardian architect early. Someone who spots the fine print before it becomes a lawsuit. • Don’t build on regulatory sand. That "quick win" you’re hacking together? If it’s not compliant, it’s a ticking time bomb. • Speak to #Regulators before they speak to you. They’re not enemies—but they are allergic to surprises. • Compliance isn’t what slows you down—it’s what keeps you in the race. 🏁 #Compliance is the cost of winning You can still be bold. You can still move fast. Just don’t be the founder who ignored the warning signs & built their startup like a house of cards—on a windy day. Build fast. But read the fine print faster. Because if you don’t…the lawyers will.

After reviewing hundreds of regulatory submissions at Complear, I've uncovered a shocking pattern that's costing the MedTech industry millions! 𝟖𝟎% 𝐨𝐟 𝐦𝐞𝐝𝐭𝐞𝐜𝐡 𝐬𝐭𝐚𝐫𝐭𝐮𝐩𝐬 𝐦𝐚𝐤𝐞 𝐭𝐡𝐞 𝐞𝐱𝐚𝐜𝐭 𝐬𝐚𝐦𝐞 𝐜𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐦𝐢𝐬𝐭𝐚𝐤𝐞 in their first FDA or CE marking application: they focus obsessively on perfecting their technology while treating regulatory strategy as a checkbox to tick later. The consequences? Devastating delays that can kill promising companies: - Brilliant AI-powered diagnostic tools delayed by 18+ months - Funding rounds missed due to extended timelines - Competitive advantages lost to better-prepared competitors - Technical debt accumulated from retrofitting compliance Here's what separates the winners from the casualties: ❌ 𝐅𝐚𝐢𝐥𝐢𝐧𝐠 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: Build first, regulate later - Develop features without considering regulatory pathways - Scramble to create documentation post-development - Face costly redesigns to meet compliance requirements - Burn through runway during extended review periods ✅ 𝐒𝐮𝐜𝐜𝐞𝐬𝐬𝐟𝐮𝐥 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: Integrate regulatory thinking from day one - Map regulatory requirements before writing code - Design clinical validation into product development - Build Quality Management Systems alongside technology - Treat regulators as partners, not obstacles The reality is harsh: regulation isn't a hurdle to overcome after innovation—it IS part of innovation in healthcare. The FDA and Notified Bodies aren't just checking boxes; they're ensuring your brilliant technology actually helps patients safely. At Complear, we've seen this transformation happen when startups shift their mindset from "regulation vs. innovation" to "regulation-driven innovation." The companies that grasp this early don't just survive regulatory review—they thrive because of it. 𝐓𝐡𝐞 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧 𝐢𝐬𝐧'𝐭 𝐰𝐡𝐞𝐭𝐡𝐞𝐫 𝐲𝐨𝐮'𝐥𝐥 𝐟𝐚𝐜𝐞 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬—𝐢𝐭'𝐬 𝐰𝐡𝐞𝐭𝐡𝐞𝐫 𝐲𝐨𝐮'𝐥𝐥 𝐛𝐞 𝐩𝐫𝐞𝐩𝐚𝐫𝐞𝐝 𝐟𝐨𝐫 𝐭𝐡𝐞𝐦. Are you building your regulatory strategy alongside your technology, or are you setting yourself up for an 18-month delay? #MedTech #Regulation #FDA #CEMarking #AIinHealthcare #MedicalDevices #RegulatoryStrategy

Roles & Responsibilities of Regulatory Affairs Specialist A Regulatory Affairs Specialist plays a crucial role in clinical research by ensuring compliance with laws, regulations, and guidelines governing clinical trials. Their responsibilities can be summarized as follows:  1. Regulatory Strategy Development - Collaborate with cross-functional teams to develop strategies that meet regulatory requirements. - Assess regulatory risks and provide solutions to ensure trial success.  2. Submission Preparation - Prepare and submit regulatory documents to agencies such as the FDA, EMA, or other local regulatory bodies. - Manage investigational new drug (IND) applications, clinical trial applications (CTAs), and amendments.  3. Regulatory Compliance - Monitor clinical trial activities to ensure compliance with regulations like Good Clinical Practice (GCP). - Stay updated on changes in global regulatory guidelines and communicate implications to the team.  4. Liaison with Regulatory Authorities - Act as the primary point of contact with regulatory agencies during the approval process. - Address queries, provide additional data, and resolve issues to facilitate timely approvals.  5. Document Management - Maintain accurate records of all regulatory submissions and correspondence. - Ensure proper documentation of trial activities to meet regulatory audit requirements.  6. Review of Trial Protocols - Assess trial protocols and informed consent documents to ensure alignment with regulatory requirements. - Provide recommendations to make the protocols compliant.  7. Risk Mitigation - Identify potential regulatory hurdles and proactively develop plans to address them. - Ensure timely reporting of adverse events or protocol deviations to regulatory authorities.  8. Training and Support - Train clinical trial teams on regulatory standards and updates. - Provide ongoing support to ensure adherence to regulatory expectations.  9. Quality Assurance - Participate in internal audits and inspections. - Ensure that clinical trial data and processes are audit-ready at all times.  10. Post-Approval Activities - Support post-marketing surveillance and ensure regulatory compliance for marketed products. - Manage regulatory submissions for label updates or new indications. The Regulatory Affairs Specialist acts as a bridge between the clinical trial team and regulatory authorities, ensuring that research progresses efficiently and ethically while adhering to stringent regulations.

Air pollution is killing us. Bangladesh can’t wait. Air pollution won’t fix itself. But here’s the truth: we don’t have to wait for governments to fix everything. Here’s what we can do RIGHT NOW (and what policymakers need to do next): 𝗦𝗵𝗼𝗿𝘁-𝗧𝗲𝗿𝗺 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 (𝗖𝗶𝘁𝗶𝘇𝗲𝗻-𝗟𝗲𝗱, 𝗜𝗺𝗺𝗲𝗱𝗶𝗮𝘁𝗲 𝗔𝗰𝘁𝗶𝗼𝗻𝘀) 1️⃣ Install low-cost air quality monitors → Crowdfund sensors and publish real-time data on social media. Awareness starts with knowing the problem. 2️⃣ Reduce vehicle idling → Run campaigns encouraging drivers to turn off engines. Small habits = big impact. 3️⃣ Enforce covering of construction sites → Citizens can report violations to authorities. Education + accountability = change. 4️⃣ Launch a viral awareness campaign → Highlight the health impacts of air pollution, especially on children and the elderly. Share personal stories. Demand action. 𝗠𝗲𝗱𝗶𝘂𝗺-𝗧𝗲𝗿𝗺 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 (𝗚𝗼𝘃𝗲𝗿𝗻𝗺𝗲𝗻𝘁 𝗜𝗻𝘁𝗲𝗿𝘃𝗲𝗻𝘁𝗶𝗼𝗻𝘀) Easy Wins: 5️⃣ Retrofit vehicles with catalytic converters → Subsidize retrofitting for clean air. 6️⃣ Ban unfit vehicles from the roads → Strict inspections = cleaner cities. 7️⃣ Reduce import duties on air purifiers → From 74% to 16% = affordable solutions for all. Harder Moves: 8️⃣ Install scrubbers in factories → Nighttime monitoring to catch illegal emissions. 9️⃣ Regulate brick kilns → Support a transition to cleaner technologies. 🔟 Modernize waste management → Waste-to-energy initiatives reduce harmful methane emissions. 𝗟𝗼𝗻𝗴-𝗧𝗲𝗿𝗺 𝗦𝘆𝘀𝘁𝗲𝗺𝗶𝗰 𝗖𝗵𝗮𝗻𝗴𝗲𝘀 Develop industrial zones away from residential areas Strengthen environmental regulations with real enforcement → Create an anti-pollution task force. Involve experts, government organizations, and businesses.

🏫 The best way to protect children from air pollution at school? Remove the pollution. Car-free school zones eliminate traffic emissions where children are most exposed. Cities from London to Bogotá are proving this works "no expensive technology needed." But while we work to reduce emissions at the source, children need protection now. This infographic shows 4 strategies, from source elimination to interim protection: → Car-free zones around schools (eliminate the source) → Safe walking routes through quiet streets (avoid exposure) → Green barriers between roads and schools (interrupt the pathway) → Clean air classrooms with filtration (protect while we fix the source) The goal is never the air purifier. The goal is a world where children don't need one. What is your city doing to reduce traffic pollution near schools? --- 📊 Based on evidence from WHO, USEPA, and scientific research 🎨 Infographic by Habitat Analytics #ChildHealth #AirQuality #SchoolHealth #CleanAir #PublicHealth World Health Organization C40 Cities Clean Air Institute Clean Air Fund World Resources Institute Clean Air Asia Clean Air for Schools Cities Alliance Gehl - Making Cities for People Bloomberg Cities Cities Today ISEE - International Society for Environmental Epidemiology Sustainable Development Solutions Network Planetizen Planetary Health Alliance The Lancet Countdown on Health and Climate Change Climate Central, Inc. EU Environment and Climate Climate Action, Sustainability and Resiliency - City and County of Denver City of Fort Collins Boulder County UN Environment Programme ONU Cambio Climático UN-Habitat (United Nations Human Settlements Programme)